|
|
Other links at Articles > Dermatology |
| 2. |
Biochemotherapy Boosts Response but Not Survival in Metastatic Melanoma
|
|
|
The addition of interferon-alpha (IFN), with or without interleukin-2 (IL-2), to standard, single-agent chemotherapy improves the response rate in patients with metastatic melanoma, according to a study in the December issue of the Journal of Clinical Oncology. Reuters Health Information
|
|
|